Related Experiment Video
Updated: Apr 23, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Ephedrine QoS: an antidote to slow, congested, bufferless NoCs
Juan Fang1, Zhicheng Yao2, Xiufeng Sui3
1College of Computer Science, Beijing University of Technology, Beijing 100124, China.
We introduce QBLESS, a novel quality-of-service (QoS)-aware bufferless network-on-chip (NoC) scheme for datacenters. QBLESS significantly enhances performance for high-priority applications by reducing contention in shared network resources.
Area of Science:
- Computer Engineering
- Network Architecture
- High-Performance Computing
Background:
- Datacenters host diverse applications, leading to resource contention, particularly on networks-on-chip (NoCs).
- Bufferless NoCs offer area and power benefits but struggle with Quality-of-Service (QoS) for latency-critical applications.
- Existing bufferless NoC designs lack robust mechanisms for guaranteeing performance to high-priority services.
Purpose of the Study:
- To propose QBLESS, a QoS-aware bufferless NoC scheme tailored for datacenter environments.
- To address the performance degradation of high-priority applications caused by resource contention in bufferless NoCs.
- To improve overall system throughput while ensuring performance guarantees for critical services.
Main Methods:
- Developed QBLESS, comprising a routing mechanism (QBLESS-R) and a congestion-control mechanism (QBLESS-CC).
- QBLESS-R is designed to minimize flit deflection for high-priority traffic.
- QBLESS-CC aims to guarantee performance for high-priority applications and enhance system throughput.
- Utilized trace-driven simulation on a 64-core system to evaluate performance.
Main Results:
- QBLESS demonstrated an average performance improvement of 33.2% for high-priority applications compared to the BLESS design.
- Achieved an average reduction of 42.8% in network hops for high-priority applications.
- Showcased enhanced overall system throughput due to effective congestion management.
Conclusions:
- QBLESS effectively provides QoS guarantees in bufferless NoCs for datacenters.
- The proposed scheme significantly enhances the performance of latency-critical applications.
- QBLESS represents a promising advancement for bufferless NoC design in demanding datacenter workloads.
Related Concept Videos
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

